Vanderpuye O A, Beville C M, McIntyre J A
Center for Reproduction and Transplantation Immunology, Methodist Hospital of Indiana, Indianapolis 46202.
Placenta. 1994 Feb-Mar;15(2):157-70. doi: 10.1016/s0143-4004(05)80452-7.
To coexist with complement, human tissues express membrane-integrated regulatory proteins that inhibit the activity of autologous complement on cell surfaces. Certain of these complement regulatory proteins act as obligatory cofactors for proteolytic inactivation of activated C4(C4b) by factor I. Extraembryonic tissues and in particular trophoblasts constitute an interface at risk from maternal complement during pregnancy. The present study examined syncytiotrophoblast plasma membrane (STM) cofactor activity for cleavage of immobilized methylamine-treated complement component C4(C4ma), a C4b analog by factor I. Membrane cofactor protein (MCP or CD46) provided most of the cofactor activity in STM preparations. Minor cofactor activity was derived from C4 binding protein that was firmly bound to STM. Cofactor activity for cleavage of C4ma at its two sites for factor I was enhanced at higher concentrations of STM and at lower concentrations cleavage at a C terminal site predominated. Soluble cofactor activity was present in STM preparations and was provided by 65 KDa, 55 KDa and 50 KDa soluble species of MCP that lacked amphiphilic properties. These results are consistent with a major role for MCP in regulation of C4 activity on the maternal-facing surfaces of extraembryonic tissues during human development. Soluble MCP may provide additional fluid phase complement regulatory activity in the maternotrophoblastic zone.
为了与补体共存,人体组织表达膜整合调节蛋白,这些蛋白可抑制自体补体在细胞表面的活性。其中某些补体调节蛋白作为I因子对活化的C4(C4b)进行蛋白水解失活的必需辅助因子。胚外组织,尤其是滋养层,在怀孕期间构成了受母体补体攻击的界面。本研究检测了合体滋养层质膜(STM)对固定化甲胺处理的补体成分C4(C4ma,一种C4b类似物)被I因子裂解的辅助因子活性。膜辅助因子蛋白(MCP或CD46)在STM制剂中提供了大部分辅助因子活性。少量辅助因子活性来自牢固结合在STM上的C4结合蛋白。在较高浓度的STM下,C4ma在其I因子的两个裂解位点的辅助因子活性增强,而在较低浓度下,C末端位点的裂解占主导。STM制剂中存在可溶性辅助因子活性,由缺乏两亲性的65 kDa、55 kDa和50 kDa可溶性MCP提供。这些结果与MCP在人类发育过程中对胚外组织面向母体表面的C4活性调节中的主要作用一致。可溶性MCP可能在母胎滋养层区域提供额外的液相补体调节活性。